TheraRadar
← Back
Data updated: Mar 29, 2026

INDICUS PHARMA

CardiovascularNeurologyOphthalmology
Generics

INDICUS PHARMA is a generic drug manufacturer focused on Cardiovascular, Neurology, Ophthalmology.

2008
Since
4
Drugs
-
Trials
47
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ACETAZOLAMIDE 2026-01-12
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2025-11-25
Manufacturing (CMC)
METFORMIN HYDROCHLORIDE 2025-11-10
Manufacturing (CMC)
LETROZOLE 2025-10-24
Labeling
LETROZOLE 2025-10-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 33%
1 drugs
Neurology 33%
1 drugs
Ophthalmology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular, Ophthalmology
UPJOHN big-pharma
Neurology, Cardiovascular, Ophthalmology
Baxter specialty
Cardiovascular, Ophthalmology
AbbVie big-pharma
Neurology, Ophthalmology
Bayer big-pharma
Cardiovascular, Ophthalmology